AMJEVITA vs DOLOBID

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 12, 2026·How we rate

Possible drug interaction. AMJEVITA and DOLOBID are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	AMJEVITA	DOLOBID
Rating	72/100	70/100
Pharmacy pays	—	~$34.89 /30
Type	RX	RX
Active ingredient	ADALIMUMAB-ATTO	DIFLUNISAL
Manufacturer	Amgen Inc	Merck
Dosage forms	Injectable	Tablet
Drug class	—	—
Boxed warning	Boxed warning	None
Treats	Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis	Rheumatoid Arthritis, Osteoarthritis, Pain

amjevita dolobid

Rating

72/100

70/100

Pharmacy pays

—

~$34.89 /30

Type

Active ingredient

ADALIMUMAB-ATTO

DIFLUNISAL

Manufacturer

Amgen Inc

Merck

Dosage forms

Injectable

Tablet

Drug class

—

Boxed warning

None

Treats

Juvenile Arthritis, Rheumatoid Arthritis, Ulcerative Colitis

Rheumatoid Arthritis, Osteoarthritis, Pain

Frequently asked questions

Which is better-rated, Amjevita or Dolobid?

By our independent rating, Amjevita scores higher — 3.6 vs 3.5 out of 5 for Dolobid. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Amjevita and Dolobid?

Amjevita contains Adalimumab-Atto, while Dolobid contains Diflunisal — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.